Ang Li

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Lymph Node Metastasis

Respiratory Failure

Cardiovascular Events

Top Venues

Infection and drug resistance

Computational and mathematical methods in medicine

BMC infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Qiu, Jiaqi Lu, Hebing Guo, Chunjing Du, Jingyuan Liu, Ang Li
Study on Respiratory Function and Hemodynamics of AIDS Patients with Respiratory Failure. Infection and drug resistance 16 (2023)
Zhili Qi, Jiaqi Lu, Pei Liu, Tian Li, Ang Li, Meili Duan
Nomogram Prediction Model of Hypernatremia on Mortality in Critically Ill Patients. Infection and drug resistance 16 (2023)
Jingjing Hao, Jingyuan Liu, Lin Pu, Chuansheng Li, Ningning Yin, Ang Li
Pulmonary Infections and Outcomes in AIDS Patients with Respiratory Failure: A 10-Year Retrospective Review. Infection and drug resistance 16 (2023)
Jingjing Hao, Jingyuan Liu, Lin Pu, Chuansheng Li, Ningning Yin, Ang Li
Pulmonary Infections and Outcomes in AIDS Patients with Respiratory Failure: A 10-Year Retrospective Review. Infection and drug resistance 16 (2023)
Zhili Qi, Jiaqi Lu, Pei Liu, Tian Li, Ang Li, Meili Duan
Nomogram Prediction Model of Hypernatremia on Mortality in Critically Ill Patients. Infection and drug resistance 16 (2023)
Yufei Chang, Linan Liu, Hui Wang, Jinghe Liu, Yuwei Liu, Chunjing Du, Mingxi Hua, Xinzhe Liu, Jingyuan Liu, Ang Li
Presepsin Predicts Severity and Secondary Bacterial Infection in COVID-19 by Bioinformatics Analysis. Computational and mathematical methods in medicine 2022 (2022)
Jiaqi Lu, Zhili Qi, Jingyuan Liu, Pei Liu, Tian Li, Meili Duan, Ang Li
Nomogram Prediction Model of Serum Chloride and Sodium Ions on the Risk of Acute Kidney Injury in Critically Ill Patients. Infection and drug resistance 15 (2022)
Jingyuan Liu, Chunjing Du, Lin Pu, Pan Xiang, Haofeng Xiong, Wen Xie, Zhihai Chen, Ang Li
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2. BMC infectious diseases 21 (1) (2021)